UnitedHealth Group (UNH) Q2 FY2026 income statement Sankey chart
Source: 10-Q · filed 2026-08-10 · SEC EDGAR · GAAP
UnitedHealth Group (UNH) Q2 FY2026 (quarter ended 2026-06-30): revenue $112.0B (+0% Y/Y), operating income $8.0B, net income $5.5B (5% margin). Sankey chart of where the money comes from and goes, from the 10-Q filed 2026-08-10.
How to read this chart
Left: revenue sources flowing into revenue. This company does not report a separate cost of revenue or gross profit, so revenue splits straight into operating expenses (red) and operating profit (green). Wider band = bigger amount; "Y/Y" = vs. a year earlier.
- Out of every 100 dollars of revenue, 4.9 dollars ended up as net profit.
- The biggest single cost is Medical Costs: $75.4B, or 67% of revenue.
- Operating margin 7.1%, up 2.5 percentage points from a year earlier (4.6%).
Worth noting
- Pre-tax income +71% Y/Y
- Operating income +55% Y/Y
- Net income +61% Y/Y
Cash flow
Operating cash flow $11.1B, capex $0.8B, free cash flow (derived = OCF − capex) $10.3B.
Key figures
| Item | Q2 FY2026 | Prior year | Y/Y | % of revenue |
|---|---|---|---|---|
| Revenue | $112.0B | $111.6B | +0% | — |
| Operating expenses | $104.0B | $106.5B | -2% | 92.9% |
| Operating income | $8.0B | $5.2B | +55% | 7.1% |
| Net income | $5.5B | $3.4B | +61% | 4.9% |
Source: UnitedHealth Group Form 10-Q filed Aug 10, 2026 (accession 0000731766-26-000197) via SEC EDGAR · Q2 FY26 = quarter ended Jun 30, 2026 · GAAP, as reported · Y/Y vs. prior-year period · Note: (±N pp) = change vs the prior-year period in percentage points · Not investment advice / 不构成投资建议 · Created 2026-10-24 · OneChart Earnings · onechartearnings.com
UnitedHealth Group · Quarters
UnitedHealth Group · Fiscal years
Earlier periods (not generated yet — press Generate, about 1–2 min) · 80
Back to 2009 (the SEC XBRL era). Each visitor can generate 3 periods a day and the whole site 30 a day; beyond that, requests are queued for the next day. Generated charts are kept permanently.
Quarters
- Q2 FY2025
- Q1 FY2025
- Q4 FY2024
- Q3 FY2024
- Q2 FY2024
- Q1 FY2024
- Q4 FY2023
- Q3 FY2023
- Q2 FY2023
- Q1 FY2023
- Q4 FY2022
- Q3 FY2022
- Q2 FY2022
- Q1 FY2022
- Q4 FY2021
- Q3 FY2021
- Q2 FY2021
- Q1 FY2021
- Q4 FY2020
- Q3 FY2020
- Q2 FY2020
- Q1 FY2020
- Q4 FY2019
- Q3 FY2019
- Q2 FY2019
- Q1 FY2019
- Q4 FY2018
- Q3 FY2018
- Q2 FY2018
- Q1 FY2018
- Q4 FY2017
- Q3 FY2017
- Q2 FY2017
- Q1 FY2017
- Q4 FY2016
- Q3 FY2016
- Q2 FY2016
- Q1 FY2016
- Q4 FY2015
- Q3 FY2015
- Q2 FY2015
- Q1 FY2015
- Q4 FY2014
- Q3 FY2014
- Q2 FY2014
- Q1 FY2014
- Q4 FY2013
- Q3 FY2013
- Q2 FY2013
- Q1 FY2013
- Q4 FY2012
- Q3 FY2012
- Q2 FY2012
- Q1 FY2012
- Q4 FY2011
- Q3 FY2011
- Q2 FY2011
- Q1 FY2011
- Q4 FY2010
- Q3 FY2010
- Q2 FY2010
- Q1 FY2010
- Q4 FY2009
- Q3 FY2009
- Q2 FY2009
Fiscal years
- FY2023
- FY2022
- FY2021
- FY2020
- FY2019
- FY2018
- FY2017
- FY2016
- FY2015
- FY2014
- FY2013
- FY2012
- FY2011
- FY2010
- FY2009